| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.88 | 0.002 | 0.902 | 5 Hydroxytryptamine uptake inhibitor | 0.902 0.002 DBMET00929 0.861 0.002 DBMET00953 | DBMET00929 | |
| 0.866 | 0.004 | 0.866 | Spasmolytic | 0.817 0.004 DBMET00929 0.709 0.005 DBMET00953 | ||
| 0.814 | 0.002 | 0.814 | Anesthetic local | 0.741 0.003 DBMET00929 0.52 0.004 DBMET00953 | ||
| 0.742 | 0.004 | 0.742 | Psychostimulant | 0.701 0.004 DBMET00929 0.551 0.008 DBMET00953 | ||
| 0.682 | 0.008 | 0.682 | Vasodilator, peripheral | 0.614 0.014 DBMET00929 0.447 0.041 DBMET00953 | ||
| 0.654 | 0.002 | 0.654 | Dopamine transporter inhibitor | 0.653 0.002 DBMET00929 0.645 0.002 DBMET00953 | ||
| 0.654 | 0.006 | 0.654 | Histamine release inhibitor | 0.532 0.02 DBMET00929 0.551 0.016 DBMET00953 | ||
| 0.623 | 0.003 | 0.689 | Adrenaline uptake inhibitor | 0.689 0.002 DBMET00929 0.58 0.003 DBMET00953 | DBMET00929 | |
| 0.608 | 0.018 | 0.608 | Aldehyde oxidase inhibitor | 0.213 0.098 DBMET00929 0.298 0.067 DBMET00953 | ||
| 0.482 | 0.004 | 0.482 | Acetylcholine M1 receptor antagonist | 0.387 0.006 DBMET00929 0.34 0.009 DBMET00953 | ||
| 0.479 | 0.008 | 0.479 | Cyclic AMP phosphodiesterase inhibitor | 0.275 0.052 DBMET00929 0.29 0.046 DBMET00953 | ||
| 0.473 | 0.005 | 0.473 | Cholinergic antagonist | 0.369 0.009 DBMET00929 0.301 0.014 DBMET00953 | ||
| 0.468 | 0.005 | 0.468 | Nav1.2 sodium channel blocker | 0.393 0.007 DBMET00929 0.337 0.011 DBMET00953 | ||
| 0.45 | 0.005 | 0.45 | Acetylcholine antagonist | 0.344 0.01 DBMET00929 0.271 0.017 DBMET00953 | ||
| 0.448 | 0.016 | 0.448 | Anticonvulsant | 0.352 0.029 DBMET00929 0.312 0.037 DBMET00953 | ||
| 0.434 | 0.004 | 0.434 | Acetylcholine muscarinic antagonist | 0.313 0.008 DBMET00929 0.252 0.014 DBMET00953 | ||
| 0.43 | 0.027 | 0.43 | Vasodilator, coronary | 0.395 0.037 DBMET00929 0.378 0.043 DBMET00953 | ||
| 0.403 | 0.005 | 0.403 | Calcium channel blocker | 0.315 0.008 DBMET00929 0.27 0.014 DBMET00953 | ||
| 0.399 | 0.005 | 0.401 | Alpha 2b adrenoreceptor antagonist | 0.401 0.005 DBMET00929 0.294 0.009 DBMET00953 | DBMET00929 | |
| 0.391 | 0.004 | 0.391 | Nav1.6 sodium channel blocker | 0.301 0.006 DBMET00929 0.235 0.011 DBMET00953 | ||
| 0.391 | 0.005 | 0.391 | Nav1.3 sodium channel blocker | 0.348 0.006 DBMET00929 0.202 0.024 DBMET00953 | ||
| 0.382 | 0.003 | 0.49 | CYP2A6 inhibitor | 0.369 0.003 DBMET00929 0.49 0.002 DBMET00953 | DBMET00953 | |
| 0.398 | 0.022 | 0.398 | Sigma receptor agonist | 0.135 0.097 DBMET00929 | ||
| 0.36 | 0.004 | 0.36 | Sigma 1 receptor antagonist | 0.218 0.004 DBMET00929 0.165 0.005 DBMET00953 | ||
| 0.363 | 0.007 | 0.363 | Antihistaminic | 0.234 0.016 DBMET00929 0.157 0.03 DBMET00953 | ||
| 0.353 | 0.008 | 0.353 | Histamine antagonist | 0.223 0.016 DBMET00929 0.146 0.03 DBMET00953 | ||
| 0.394 | 0.051 | 0.478 | Antithrombotic | 0.37 0.058 DBMET00929 0.478 0.032 DBMET00953 | DBMET00953 | |
| 0.347 | 0.004 | 0.347 | Dopamine uptake inhibitor | 0.338 0.004 DBMET00929 0.209 0.006 DBMET00953 | ||
| 0.346 | 0.005 | 0.346 | Nav1.1 sodium channel blocker | 0.271 0.01 DBMET00929 0.255 0.012 DBMET00953 | ||
| 0.315 | 0.006 | 0.315 | Histamine H1 receptor antagonist | 0.192 0.016 DBMET00929 0.159 0.022 DBMET00953 | ||
| 0.327 | 0.028 | 0.327 | Anesthetic general | 0.215 0.067 DBMET00929 0.234 0.057 DBMET00953 | ||
| 0.337 | 0.043 | 0.337 | Cardiotonic | 0.249 0.083 DBMET00929 0.293 0.059 DBMET00953 | ||
| 0.294 | 0.003 | 0.294 | Histamine N-methyltransferase inhibitor | 0.176 0.008 DBMET00929 0.22 0.004 DBMET00953 | ||
| 0.289 | 0.006 | 0.289 | Sigma receptor antagonist | 0.166 0.01 DBMET00929 0.121 0.014 DBMET00953 | ||
| 0.39 | 0.109 | 0.442 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.442 0.067 DBMET00929 0.39 0.11 DBMET00953 | DBMET00929 | |
| 0.282 | 0.004 | 0.282 | Acetylcholine M4 receptor antagonist | 0.139 0.012 DBMET00929 0.11 0.022 DBMET00953 | ||
| 0.281 | 0.007 | 0.284 | 5 Hydroxytryptamine 3E antagonist | 0.284 0.007 DBMET00929 0.266 0.01 DBMET00953 | DBMET00929 | |
| 0.278 | 0.004 | 0.278 | Sphingomyelinase inhibitor | 0.236 0.005 DBMET00929 0.235 0.005 DBMET00953 | ||
| 0.298 | 0.047 | 0.298 | Potassium channel blocker | 0.162 0.123 DBMET00929 | ||
| 0.248 | 0.013 | 0.248 | 5 Hydroxytryptamine 2C antagonist | 0.175 0.021 DBMET00929 0.135 0.031 DBMET00953 | ||
| 0.257 | 0.026 | 0.292 | MAP kinase kinase 3 inhibitor | 0.256 0.026 DBMET00929 0.292 0.009 DBMET00953 | DBMET00953 | |
| 0.26 | 0.03 | 0.26 | Lipocortins synthesis antagonist | 0.161 0.091 DBMET00929 0.156 0.097 DBMET00953 | ||
| 0.327 | 0.099 | 0.362 | Immunosuppressant | 0.292 0.12 DBMET00929 0.362 0.08 DBMET00953 | DBMET00953 | |
| 0.28 | 0.055 | 0.28 | HERG channel blocker | 0.149 0.132 DBMET00929 | ||
| 0.307 | 0.085 | 0.394 | Calcium channel activator | 0.394 0.027 DBMET00929 0.39 0.028 DBMET00953 | DBMET00929 | |
| 0.223 | 0.005 | 0.223 | Acetylcholine M2 receptor antagonist | 0.131 0.014 DBMET00929 0.094 0.023 DBMET00953 | ||
| 0.225 | 0.014 | 0.225 | Arachidonic acid antagonist | 0.189 0.044 DBMET00929 0.2 0.033 DBMET00953 | ||
| 0.299 | 0.092 | 0.315 | Cholesterol antagonist | 0.315 0.082 DBMET00929 0.292 0.096 DBMET00953 | DBMET00929 | |
| 0.217 | 0.012 | 0.217 | Mediator release inhibitor | 0.217 0.012 DBMET00929 0.179 0.019 DBMET00953 | ||
| 0.265 | 0.062 | 0.265 | Vasodilator | 0.237 0.077 DBMET00929 0.237 0.077 DBMET00953 | ||
| 0.217 | 0.015 | 0.217 | Alpha 2 adrenoreceptor antagonist | 0.217 0.015 DBMET00929 0.153 0.026 DBMET00953 | ||
| 0.213 | 0.012 | 0.213 | Acetylcholine nicotinic antagonist | 0.186 0.014 DBMET00929 0.149 0.02 DBMET00953 | ||
| 0.213 | 0.012 | 0.213 | Alpha 2a adrenoreceptor antagonist | 0.207 0.013 DBMET00929 0.177 0.017 DBMET00953 | ||
| 0.206 | 0.005 | 0.206 | Interferon agonist | 0.114 0.02 DBMET00929 0.142 0.011 DBMET00953 | ||
| 0.225 | 0.025 | 0.225 | 5 Hydroxytryptamine 2 antagonist | 0.18 0.035 DBMET00929 0.119 0.06 DBMET00953 | ||
| 0.204 | 0.005 | 0.227 | Histamine H2 receptor antagonist | 0.227 0.004 DBMET00929 0.149 0.01 DBMET00953 | DBMET00929 | |
| 0.202 | 0.005 | 0.202 | Acetylcholine M5 receptor antagonist | 0.136 0.009 DBMET00929 0.099 0.018 DBMET00953 | ||
| 0.214 | 0.018 | 0.214 | 5 Hydroxytryptamine 2A antagonist | 0.148 0.029 DBMET00929 0.112 0.041 DBMET00953 | ||
| 0.259 | 0.063 | 0.259 | Potassium channel (Voltage-sensitive) blocker | 0.148 0.139 DBMET00929 | ||
| 0.192 | 0.014 | 0.192 | Calcium antagonist | 0.1 0.048 DBMET00929 0.118 0.036 DBMET00953 | ||
| 0.186 | 0.011 | 0.252 | Dopamine agonist | 0.24 0.007 DBMET00929 0.252 0.007 DBMET00953 | DBMET00953 | |
| 0.201 | 0.026 | 0.201 | 5 Hydroxytryptamine 2B antagonist | 0.127 0.054 DBMET00929 0.114 0.066 DBMET00953 | ||
| 0.19 | 0.019 | 0.19 | Calcium channel (voltage-sensitive) blocker | 0.156 0.031 DBMET00929 0.127 0.049 DBMET00953 | ||
| 0.161 | 0.01 | 0.161 | Acetylcholine M3 receptor antagonist | 0.099 0.018 DBMET00929 0.076 0.028 DBMET00953 | ||
| 0.322 | 0.171 | 0.322 | Caspase 9 stimulant | |||
| 0.208 | 0.066 | 0.208 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.166 0.115 DBMET00953 | ||
| 0.145 | 0.004 | 0.145 | Estrogen-related receptor beta agonist | 0.101 0.023 DBMET00929 0.091 0.039 DBMET00953 | ||
| 0.183 | 0.054 | 0.184 | ATPase inhibitor | 0.184 0.053 DBMET00929 | DBMET00929 | |
| 0.292 | 0.164 | 0.57 | Calcium channel L-type activator | 0.57 0.009 DBMET00929 0.339 0.126 DBMET00953 | DBMET00929 | |
| 0.13 | 0.006 | 0.13 | Interferon inducer | 0.093 0.015 DBMET00929 0.116 0.008 DBMET00953 | ||
| 0.123 | 0.003 | 0.123 | GABA uptake inhibitor | 0.07 0.007 DBMET00929 0.103 0.004 DBMET00953 | ||
| 0.131 | 0.013 | 0.131 | Calcium channel L-type blocker | 0.102 0.024 DBMET00929 0.086 0.033 DBMET00953 | ||
| 0.26 | 0.146 | 0.31 | GABA C receptor rho-3 antagonist | 0.277 0.132 DBMET00929 0.31 0.109 DBMET00953 | DBMET00953 | |
| 0.15 | 0.038 | 0.15 | Calcium channel N-type blocker | 0.142 0.043 DBMET00929 0.114 0.072 DBMET00953 | ||
| 0.243 | 0.133 | 0.273 | Transcription factor NF kappa B inhibitor | 0.272 0.112 DBMET00929 0.273 0.111 DBMET00953 | DBMET00953 | |
| 0.12 | 0.011 | 0.172 | NMDA 2C receptor antagonist | 0.084 0.022 DBMET00929 0.172 0.005 DBMET00953 | DBMET00953 | |
| 0.156 | 0.047 | 0.156 | 5 Hydroxytryptamine antagonist | 0.135 0.056 DBMET00929 0.095 0.084 DBMET00953 | ||
| 0.157 | 0.051 | 0.189 | Adenylate cyclase stimulant | 0.189 0.019 DBMET00929 0.169 0.036 DBMET00953 | DBMET00929 | |
| 0.226 | 0.122 | 0.288 | Insulysin inhibitor | 0.242 0.104 DBMET00929 0.288 0.066 DBMET00953 | DBMET00953 | |
| 0.146 | 0.042 | 0.19 | Vanilloid 1 agonist | 0.19 0.015 DBMET00929 0.182 0.018 DBMET00953 | DBMET00929 | |
| 0.148 | 0.049 | 0.149 | Ca2+-transporting ATPase inhibitor | 0.138 0.079 DBMET00929 0.149 0.044 DBMET00953 | DBMET00953 | |
| 0.128 | 0.037 | 0.135 | Adenylate kinase inhibitor | 0.093 0.079 DBMET00929 0.135 0.033 DBMET00953 | DBMET00953 | |
| 0.108 | 0.019 | 0.108 | T cell inhibitor | 0.081 0.061 DBMET00929 0.085 0.05 DBMET00953 | ||
| 0.11 | 0.023 | 0.112 | Na+ K+ transporting ATPase inhibitor | 0.079 0.051 DBMET00929 0.112 0.022 DBMET00953 | DBMET00953 | |
| 0.156 | 0.073 | 0.156 | Diuretic | 0.117 0.109 DBMET00929 0.131 0.093 DBMET00953 | ||
| 0.141 | 0.061 | 0.169 | Alpha-N-acetylglucosaminidase inhibitor | 0.157 0.051 DBMET00929 0.169 0.045 DBMET00953 | DBMET00953 | |
| 0.185 | 0.105 | 0.185 | Hypolipemic | 0.147 0.14 DBMET00929 | ||
| 0.126 | 0.05 | 0.126 | Photosensitizer | 0.1 0.088 DBMET00929 0.118 0.06 DBMET00953 | ||
| 0.084 | 0.008 | 0.084 | Squalene epoxidase inhibitor | 0.058 0.023 DBMET00929 0.05 0.034 DBMET00953 | ||
| 0.112 | 0.036 | 0.359 | Toll-Like receptor 3 antagonist | 0.271 0.004 DBMET00929 0.359 0.003 DBMET00953 | DBMET00953 | |
| 0.132 | 0.057 | 0.132 | Alkylator | 0.129 0.06 DBMET00929 | ||
| 0.093 | 0.018 | 0.093 | Calcium channel T-type blocker | 0.061 0.036 DBMET00929 0.064 0.033 DBMET00953 | ||
| 0.115 | 0.04 | 0.142 | MAP kinase kinase 1 inhibitor | 0.128 0.028 DBMET00929 0.142 0.02 DBMET00953 | DBMET00953 | |
| 0.091 | 0.018 | 0.091 | 5 Hydroxytryptamine 6 antagonist | 0.073 0.027 DBMET00929 0.067 0.031 DBMET00953 | ||
| 0.157 | 0.087 | 0.169 | Antipruritic | 0.169 0.075 DBMET00929 0.159 0.084 DBMET00953 | DBMET00929 | |
| 0.116 | 0.047 | 0.116 | Gastric antisecretory | 0.116 0.047 DBMET00929 | ||
| 0.073 | 0.006 | 0.118 | Cytokine production stimulant | 0.072 0.006 DBMET00929 0.118 0.004 DBMET00953 | DBMET00953 | |
| 0.109 | 0.045 | 0.158 | Glutamate (mGluR7) agonist | 0.158 0.009 DBMET00929 0.125 0.026 DBMET00953 | DBMET00929 | |
| 0.099 | 0.037 | 0.099 | 5 Hydroxytryptamine 1 antagonist | 0.081 0.046 DBMET00929 | ||
| 0.065 | 0.005 | 0.077 | Calcium-sensing receptor antagonist | 0.077 0.004 DBMET00929 0.067 0.005 DBMET00953 | DBMET00929 | |
| 0.081 | 0.022 | 0.081 | Acyl-CoA dehydrogenase inhibitor | 0.047 0.046 DBMET00929 0.063 0.031 DBMET00953 | ||
| 0.098 | 0.043 | 0.098 | Bromodomain-containing protein 2 inhibitor | 0.086 0.064 DBMET00929 | ||
| 0.107 | 0.054 | 0.107 | Anabolic | 0.092 0.075 DBMET00953 | ||
| 0.066 | 0.014 | 0.067 | Adenylate cyclase 1 inhibitor | 0.067 0.013 DBMET00929 0.062 0.017 DBMET00953 | DBMET00929 | |
| 0.07 | 0.018 | 0.092 | 5 Hydroxytryptamine 1B agonist | 0.092 0.008 DBMET00929 0.075 0.015 DBMET00953 | DBMET00929 | |
| 0.127 | 0.076 | 0.151 | Interleukin 4 antagonist | 0.122 0.083 DBMET00929 0.151 0.049 DBMET00953 | DBMET00953 | |
| 0.088 | 0.038 | 0.088 | Estrogen receptor alpha antagonist | |||
| 0.2 | 0.151 | 0.266 | 5 Hydroxytryptamine uptake stimulant | 0.203 0.145 DBMET00929 0.266 0.067 DBMET00953 | DBMET00953 | |
| 0.096 | 0.048 | 0.117 | NADH dehydrogenase inhibitor | 0.083 0.068 DBMET00929 0.117 0.03 DBMET00953 | DBMET00953 | |
| 0.077 | 0.03 | 0.108 | Beta adrenoreceptor antagonist | 0.108 0.013 DBMET00929 0.085 0.024 DBMET00953 | DBMET00929 | |
| 0.102 | 0.055 | 0.104 | Alpha adrenoreceptor antagonist | 0.104 0.054 DBMET00929 | DBMET00929 | |
| 0.183 | 0.137 | 0.367 | 5 Hydroxytryptamine release stimulant | 0.272 0.079 DBMET00929 0.367 0.053 DBMET00953 | DBMET00953 | |
| 0.067 | 0.026 | 0.067 | Ca(v)3.2 blocker | |||
| 0.043 | 0.004 | 0.043 | Estrogen-related receptor gamma antagonist | 0.033 0.01 DBMET00929 | ||
| 0.049 | 0.01 | 0.049 | 5 Hydroxytryptamine 1D agonist | 0.037 0.015 DBMET00929 | ||
| 0.185 | 0.147 | 0.186 | DNA synthesis inhibitor | 0.186 0.144 DBMET00953 | DBMET00953 | |
| 0.119 | 0.082 | 0.127 | Antibacterial (Helicobacter pylori) | 0.122 0.079 DBMET00929 0.127 0.072 DBMET00953 | DBMET00953 | |
| 0.049 | 0.013 | 0.057 | Retinoid X receptor antagonist | 0.041 0.022 DBMET00929 0.057 0.007 DBMET00953 | DBMET00953 | |
| 0.095 | 0.059 | 0.132 | Antiadrenergic | 0.132 0.041 DBMET00929 | DBMET00929 | |
| 0.049 | 0.012 | 0.049 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.079 | 0.043 | 0.079 | HIV-1 reverse transcriptase inhibitor | 0.068 0.051 DBMET00929 0.077 0.044 DBMET00953 | ||
| 0.104 | 0.07 | 0.104 | DNA intercalator | |||
| 0.1 | 0.066 | 0.107 | Alpha 2c adrenoreceptor antagonist | 0.107 0.06 DBMET00929 | DBMET00929 | |
| 0.092 | 0.059 | 0.127 | Adrenaline antagonist | 0.127 0.041 DBMET00929 | DBMET00929 | |
| 0.189 | 0.156 | 0.245 | Tyrosine 3 hydroxylase inhibitor | 0.196 0.143 DBMET00929 0.245 0.073 DBMET00953 | DBMET00953 | |
| 0.106 | 0.073 | 0.106 | Acetylcholine release stimulant | |||
| 0.044 | 0.011 | 0.05 | Retinoid X alpha receptor antagonist | 0.037 0.019 DBMET00929 0.05 0.006 DBMET00953 | DBMET00953 | |
| 0.089 | 0.057 | 0.141 | Ornithine decarboxylase inhibitor | 0.117 0.028 DBMET00929 0.141 0.014 DBMET00953 | DBMET00953 | |
| 0.074 | 0.043 | 0.074 | 5 Hydroxytryptamine 1A antagonist | 0.062 0.052 DBMET00929 | ||
| 0.07 | 0.04 | 0.07 | Dopamine D1 antagonist | |||
| 0.072 | 0.042 | 0.072 | Acetylcholine M5 receptor agonist | |||
| 0.182 | 0.152 | 0.182 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.05 | 0.022 | 0.071 | Histamine H2 receptor agonist | 0.071 0.01 DBMET00929 0.069 0.01 DBMET00953 | DBMET00929 | |
| 0.105 | 0.081 | 0.105 | Cholesterol synthesis inhibitor | |||
| 0.094 | 0.07 | 0.185 | Check point kinase 2 inhibitor | 0.104 0.061 DBMET00929 0.185 0.021 DBMET00953 | DBMET00953 | |
| 0.127 | 0.105 | 0.2 | Phospholipase A2 inhibitor | 0.2 0.043 DBMET00953 | DBMET00953 | |
| 0.051 | 0.029 | 0.063 | Histamine H4 receptor antagonist | 0.054 0.026 DBMET00929 0.063 0.016 DBMET00953 | DBMET00953 | |
| 0.057 | 0.036 | 0.057 | Acetylcholine muscarinic agonist | |||
| 0.055 | 0.036 | 0.061 | Thromboxane synthase inhibitor | 0.059 0.029 DBMET00929 0.061 0.026 DBMET00953 | DBMET00953 | |
| 0.053 | 0.034 | 0.053 | Alpha 1L adrenoreceptor antagonist | |||
| 0.131 | 0.114 | 0.131 | Heat shock protein 70 antagonist | |||
| 0.116 | 0.098 | 0.116 | Lipid peroxidase inhibitor | |||
| 0.047 | 0.03 | 0.047 | Farnesyltransferase inhibitor | 0.047 0.03 DBMET00953 | ||
| 0.034 | 0.018 | 0.034 | Cholesterol ester transfer protein antagonist | 0.03 0.023 DBMET00953 | ||
| 0.073 | 0.058 | 0.073 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.03 | 0.016 | 0.03 | Sigma 2 receptor antagonist | |||
| 0.051 | 0.037 | 0.082 | NMDA 2A receptor antagonist | 0.082 0.019 DBMET00929 0.075 0.022 DBMET00953 | DBMET00929 | |
| 0.052 | 0.039 | 0.054 | Alpha-mannosidase inhibitor | 0.054 0.037 DBMET00953 | DBMET00953 | |
| 0.062 | 0.049 | 0.069 | Beta 3 adrenoreceptor antagonist | 0.069 0.036 DBMET00929 | DBMET00929 | |
| 0.022 | 0.009 | 0.022 | Histone-lysine N-methyltransferase EZH2 inhibitor | 0.022 0.009 DBMET00929 0.02 0.015 DBMET00953 | ||
| 0.021 | 0.009 | 0.021 | Estrogen-related receptor gamma agonist | 0.019 0.011 DBMET00929 | ||
| 0.098 | 0.086 | 0.098 | Adenylate cyclase inhibitor | |||
| 0.184 | 0.172 | 0.238 | Gastrin inhibitor | 0.238 0.094 DBMET00929 | DBMET00929 | |
| 0.168 | 0.157 | 0.208 | Nitric-oxide synthase stimulant | 0.191 0.106 DBMET00929 0.208 0.076 DBMET00953 | DBMET00953 | |
| 0.041 | 0.031 | 0.041 | Acetylcholine M1 receptor agonist | |||
| 0.05 | 0.04 | 0.059 | Histamine agonist | 0.059 0.028 DBMET00929 0.048 0.043 DBMET00953 | DBMET00929 | |
| 0.086 | 0.079 | 0.099 | UDP-glucose 4-epimerase inhibitor | 0.099 0.062 DBMET00953 | DBMET00953 | |
| 0.228 | 0.221 | 0.228 | MAP kinase kinase 6 inhibitor | |||
| 0.05 | 0.043 | 0.055 | Nicotinic alpha3beta2 receptor antagonist | 0.055 0.034 DBMET00929 | DBMET00929 | |
| 0.109 | 0.102 | 0.109 | Cytokine production inhibitor | |||
| 0.102 | 0.095 | 0.102 | Estrogen antagonist | |||
| 0.084 | 0.078 | 0.139 | Aminopeptidase B inhibitor | 0.139 0.042 DBMET00953 | DBMET00953 | |
| 0.039 | 0.035 | 0.039 | Histamine H3 receptor antagonist | |||
| 0.084 | 0.08 | 0.095 | Creatine kinase inhibitor | 0.095 0.065 DBMET00953 | DBMET00953 | |
| 0.066 | 0.062 | 0.078 | Phospholipase D inhibitor | 0.078 0.037 DBMET00929 | DBMET00929 | |
| 0.08 | 0.077 | 0.11 | Triose-phosphate isomerase inhibitor | 0.11 0.039 DBMET00953 | DBMET00953 | |
| 0.024 | 0.022 | 0.024 | Urotensin II agonist | |||
| 0.046 | 0.044 | 0.046 | H+/K+-transporting ATPase inhibitor | |||
| 0.038 | 0.037 | 0.038 | Guanylate cyclase inhibitor | |||
| 0.067 | 0.067 | 0.08 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.08 0.038 DBMET00953 | DBMET00953 | |
| 0.091 | 0.092 | 0.174 | GABA C receptor antagonist | 0.174 0.02 DBMET00953 | DBMET00953 | |
| 0.051 | 0.052 | 0.094 | Biliverdin reductase inhibitor | 0.094 0.02 DBMET00953 | DBMET00953 | |
| 0.023 | 0.026 | 0.026 | Acid ceramidase inhibitor | 0.026 0.017 DBMET00929 | DBMET00929 | |
| 0.024 | 0.027 | 0.028 | Myristoyl transferase inhibitor | 0.028 0.017 DBMET00929 | DBMET00929 | |
| 0.032 | 0.036 | 0.037 | Diamine oxidase inhibitor | 0.037 0.026 DBMET00953 | DBMET00953 | |
| 0.061 | 0.066 | 0.08 | Aminopeptidase I inhibitor | 0.08 0.042 DBMET00953 | DBMET00953 | |
| 0.03 | 0.038 | 0.037 | Glutamate (mGluR3) antagonist | 0.037 0.025 DBMET00953 | DBMET00953 | |
| 0.057 | 0.065 | 0.064 | Beta 2 adrenoreceptor agonist | 0.064 0.035 DBMET00929 0.063 0.036 DBMET00953 | DBMET00929 | |
| 0.053 | 0.062 | 0.056 | 5 Hydroxytryptamine 5A antagonist | 0.056 0.053 DBMET00929 | DBMET00929 | |
| 0.013 | 0.023 | 0.031 | Sodium/hydrogen exchanger inhibitor | 0.016 0.014 DBMET00929 0.031 0.005 DBMET00953 | DBMET00953 | |
| 0.037 | 0.047 | 0.046 | Mannosidase inhibitor | 0.046 0.03 DBMET00953 | DBMET00953 | |
| 0.046 | 0.058 | 0.057 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.057 0.037 DBMET00953 | DBMET00953 | |
| 0.034 | 0.046 | 0.04 | Glycine transporter 2 inhibitor | 0.04 0.038 DBMET00953 | DBMET00953 | |
| 0.046 | 0.06 | 0.055 | Epithelial sodium channel blocker | 0.055 0.037 DBMET00953 | DBMET00953 | |
| 0.091 | 0.107 | 0.117 | MAP kinase kinase inhibitor | 0.101 0.093 DBMET00929 0.117 0.076 DBMET00953 | DBMET00953 | |
| 0.039 | 0.063 | 0.051 | Alpha 1d adrenoreceptor antagonist | 0.051 0.048 DBMET00929 | DBMET00929 | |
| 0.01 | 0.034 | 0.026 | Alpha 2a adrenoreceptor agonist | 0.026 0.006 DBMET00929 0.021 0.009 DBMET00953 | DBMET00929 | |
| 0.149 | 0.174 | 0.181 | DNA damaging | 0.181 0.133 DBMET00953 | DBMET00953 | |
| 0.077 | 0.104 | 0.134 | Ferrochelatase inhibitor | 0.134 0.045 DBMET00953 | DBMET00953 | |
| 0.072 | 0.1 | 0.095 | Urease inhibitor | 0.095 0.073 DBMET00953 | DBMET00953 | |
| 0.09 | 0.118 | 0.108 | Aldehyde dehydrogenase inhibitor | 0.108 0.086 DBMET00953 | DBMET00953 | |
| 0.034 | 0.065 | 0.066 | Beta 2 adrenoreceptor antagonist | 0.066 0.019 DBMET00929 0.054 0.03 DBMET00953 | DBMET00929 | |
| 0.06 | 0.094 | 0.114 | Adrenaline agonist | 0.114 0.028 DBMET00929 0.075 0.065 DBMET00953 | DBMET00929 | |
| 0.038 | 0.073 | 0.045 | Beta adrenoreceptor agonist | 0.045 0.03 DBMET00929 | DBMET00929 | |
| 0.091 | 0.126 | 0.14 | Cathepsin H inhibitor | 0.14 0.054 DBMET00953 | DBMET00953 | |
| 0.077 | 0.113 | 0.098 | Carbonic anhydrase XV inhibitor | 0.098 0.069 DBMET00953 | DBMET00953 | |
| 0.111 | 0.147 | 0.15 | GABA C receptor rho-2 antagonist | 0.15 0.074 DBMET00929 | DBMET00929 | |
| 0.127 | 0.164 | 0.149 | Phospholipase C inhibitor | 0.149 0.107 DBMET00953 | DBMET00953 | |
| 0.01 | 0.047 | 0.02 | Alpha 2c adrenoreceptor agonist | 0.02 0.01 DBMET00929 | DBMET00929 | |
| 0.086 | 0.129 | 0.109 | Cyclooxygenase 3 inhibitor | 0.109 0.091 DBMET00953 | DBMET00953 | |
| 0.016 | 0.062 | 0.024 | Thyroid hormone agonist | 0.024 0.021 DBMET00953 | DBMET00953 | |
| 0.149 | 0.198 | 0.249 | Peptidyltransferase inhibitor | 0.249 0.052 DBMET00929 0.232 0.065 DBMET00953 | DBMET00929 | |
| 0.123 | 0.172 | 0.164 | Succinate dehydrogenase inhibitor | 0.164 0.089 DBMET00953 | DBMET00953 | |
| 0.054 | 0.106 | 0.091 | Glycine receptor agonist | 0.091 0.027 DBMET00953 | DBMET00953 | |
| 0.014 | 0.067 | 0.019 | Toll-Like receptor 8 agonist | 0.019 0.018 DBMET00953 | DBMET00953 | |
| 0.05 | 0.104 | 0.082 | Glutamate dehydrogenase inhibitor | 0.082 0.042 DBMET00953 | DBMET00953 | |
| 0.038 | 0.093 | 0.061 | Phosphofructokinase-1 inhibitor | 0.061 0.055 DBMET00953 | DBMET00953 | |
| 0.018 | 0.073 | 0.083 | Kinesin-like protein 1 inhibitor | 0.083 0.01 DBMET00953 | DBMET00953 | |
| 0.018 | 0.073 | 0.083 | Kinesin antagonist | 0.083 0.01 DBMET00953 | DBMET00953 | |
| 0.022 | 0.077 | 0.031 | Glutamate (mGluR3) agonist | 0.031 0.024 DBMET00953 | DBMET00953 | |
| 0.011 | 0.069 | 0.025 | Uridine phosphorylase inhibitor | 0.025 0.023 DBMET00953 | DBMET00953 | |
| 0.074 | 0.133 | 0.106 | Amylase inhibitor | 0.106 0.091 DBMET00953 | DBMET00953 | |
| 0.122 | 0.185 | 0.173 | Immunostimulant | 0.173 0.137 DBMET00953 | DBMET00953 | |
| 0.128 | 0.193 | 0.151 | Histone acetyltransferase inhibitor | 0.151 0.138 DBMET00929 0.147 0.145 DBMET00953 | DBMET00929 | |
| 0.035 | 0.103 | 0.053 | Carbonic anhydrase stimulant | 0.053 0.05 DBMET00929 0.052 0.051 DBMET00953 | DBMET00929 | |
| 0.032 | 0.102 | 0.059 | Carbamoyl phosphate synthetase inhibitor | 0.059 0.044 DBMET00953 | DBMET00953 | |
| 0.049 | 0.122 | 0.073 | Glutamate (mGluR6) antagonist | 0.073 0.033 DBMET00953 | DBMET00953 | |
| 0.065 | 0.138 | 0.091 | Nitric-oxide synthase inhibitor | 0.091 0.075 DBMET00929 | DBMET00929 | |
| 0.041 | 0.116 | 0.058 | Corticotropin releasing factor 2 receptor antagonist | 0.058 0.051 DBMET00953 | DBMET00953 | |
| 0.057 | 0.131 | 0.076 | Glutathione S-transferase inhibitor | 0.076 0.067 DBMET00953 | DBMET00953 | |
| 0.034 | 0.11 | 0.063 | Alpha 2 adrenoreceptor agonist | 0.063 0.039 DBMET00929 | DBMET00929 | |
| 0.097 | 0.173 | 0.125 | Papain-like protease (SARS coronavirus) inhibitor | 0.125 0.069 DBMET00929 | DBMET00929 | |
| 0.116 | 0.193 | 0.237 | Platelet antagonist | 0.237 0.078 DBMET00953 | DBMET00953 | |
| 0.036 | 0.114 | 0.092 | Phenylalanine 4-hydroxylase inhibitor | 0.061 0.056 DBMET00929 0.092 0.03 DBMET00953 | DBMET00953 | |
| 0.142 | 0.22 | 0.166 | RNA-directed DNA polymerase inhibitor | 0.166 0.161 DBMET00953 | DBMET00953 | |
| 0.028 | 0.107 | 0.055 | Beta 1 adrenoreceptor antagonist | 0.055 0.04 DBMET00929 | DBMET00929 | |
| 0.061 | 0.142 | 0.079 | mTOR complex 2 inhibitor | 0.079 0.073 DBMET00929 | DBMET00929 | |
| 0.05 | 0.135 | 0.083 | Keratolytic | 0.083 0.044 DBMET00953 | DBMET00953 | |
| 0.208 | 0.293 | 0.319 | 5 Hydroxytryptamine release inhibitor | 0.319 0.145 DBMET00953 | DBMET00953 | |
| 0.026 | 0.115 | 0.13 | Alcohol oxidase inhibitor | 0.13 0.013 DBMET00953 | DBMET00953 | |
| 0.062 | 0.156 | 0.114 | GABA C receptor rho-1 antagonist | 0.087 0.083 DBMET00929 0.114 0.045 DBMET00953 | DBMET00953 | |
| 0.057 | 0.153 | 0.073 | MAP kinase kinase 7 inhibitor | 0.073 0.068 DBMET00953 | DBMET00953 | |
| 0.017 | 0.125 | 0.05 | Ornithine carbamoyltransferase inhibitor | 0.05 0.039 DBMET00953 | DBMET00953 | |
| 0.026 | 0.135 | 0.078 | 5 Hydroxytryptamine 2A agonist | 0.078 0.029 DBMET00953 | DBMET00953 | |
| 0.075 | 0.187 | 0.16 | Peroxidase inhibitor | 0.16 0.073 DBMET00953 | DBMET00953 | |
| 0.091 | 0.204 | 0.126 | Hemostatic | 0.126 0.102 DBMET00953 | DBMET00953 | |
| 0.031 | 0.147 | 0.083 | Porphobilinogen synthase inhibitor | 0.083 0.045 DBMET00953 | DBMET00953 | |
| 0.051 | 0.175 | 0.147 | GABA C receptor agonist | 0.147 0.035 DBMET00953 | DBMET00953 | |
| 0.087 | 0.217 | 0.469 | Interleukin antagonist | 0.469 0.022 DBMET00953 | DBMET00953 | |
| 0.031 | 0.163 | 0.077 | Glutamate decarboxylase inhibitor | 0.077 0.047 DBMET00953 | DBMET00953 | |
| 0.057 | 0.194 | 0.121 | Vanilloid agonist | 0.079 0.073 DBMET00929 0.121 0.018 DBMET00953 | DBMET00953 | |
| 0.056 | 0.198 | 0.099 | Beta amyloid protein antagonist | 0.099 0.091 DBMET00953 | DBMET00953 | |
| 0.147 | 0.305 | 0.267 | Antibacterial | 0.267 0.162 DBMET00953 | DBMET00953 | |
| 0.142 | 0.325 | 0.243 | Analgesic | 0.243 0.189 DBMET00929 | DBMET00929 | |
| 0.021 | 0.205 | 0.053 | Myc inhibitor | 0.053 0.04 DBMET00929 | DBMET00929 | |
| 0.05 | 0.236 | 0.194 | Thrombolytic | 0.194 0.055 DBMET00953 | DBMET00953 | |
| 0.102 | 0.293 | 0.23 | Superoxide dismutase inhibitor | 0.23 0.089 DBMET00953 | DBMET00953 | |
| 0.021 | 0.38 | 0.05 | Parathyroid hormone antagonist | 0.05 0.022 DBMET00953 | DBMET00953 | |
| 0.044 | 0.407 | 0.087 | Interleukin 12 antagonist | 0.087 0.078 DBMET00953 | DBMET00953 | |
| 0.022 | 0.442 | 0.047 | Alpha 1b adrenoreceptor agonist | 0.047 0.044 DBMET00929 | DBMET00929 | |
| 0.075 | 0.627 | 0.223 | Interleukin 2 agonist | 0.223 0.152 DBMET00953 | DBMET00953 | |
| 0.04 | 0.675 | 0.121 | Growth hormone agonist | 0.121 0.12 DBMET00953 | DBMET00953 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |